首頁 › 白血病 › 紐約州 › New York City
New York City, NY 的 白血病 臨床試驗
19 項針對 白血病 的研究正在 New York City（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
招募中1/2 期
- Montefiore Medical Center, New York
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
招募中2 期
- Weill Cornell, New York
A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes
招募中2 期
- Memorial Sloan Kettering Cancer Center, New York
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
招募中2 期
- Columbia University Medical Center New York Presbyterian, New York
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
招募中1 期
- Memorial Sloan Kettering Cancer Center, New York
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
招募中3 期
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University, New York
- Weill Cornell Medical Center, New York
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
招募中1 期
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical College-NY Presbyterian Hospital, New York
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
招募中1/2 期
- Research Site, New York
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
招募中2 期
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
CD4CAR for CD4+ Leukemia and Lymphoma
招募中1 期
- Albert Einstein Health Network, New York
A Study of Revumenib and Mezigdomide in People With Leukemia
招募中1/2 期
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
招募中1/2 期
- Dren Investigational Site 1, New York
- Dren Investigational Site 2, New York
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
招募中歡迎健康志工
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
招募中2 期
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
招募中2/3 期
- Perlmutter Cancer Center - 34th Street, New York
- Icahn School of Medicine at Mount Sinai, New York
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
招募中1 期
- New York - Presbyterian / Weill Cornell Medicine, New York
- Mount Sinai - Ruttenberg Treatment Center, New York
- Columbia University Medical Center, New York
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
招募中觀察性研究歡迎健康志工
- Memorial Sloan Kettering Cancer Center, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, New York
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
招募中1 期
- Memorial Sloan Kettering Cancer Center, New York
其他城市的 白血病 試驗
- Houston, TX28 項研究
- Boston, MA25 項研究
- Los Angeles, CA16 項研究
- Chicago, IL16 項研究
- Durham, NC13 項研究
- Nashville, TN12 項研究
- Columbus, OH12 項研究
- Philadelphia, PA12 項研究
- Baldwin Park, CA12 項研究
- Milwaukee, WI11 項研究
- Seattle, WA11 項研究
- Atlanta, GA11 項研究
New York City 的其他研究
- 乳癌136 項研究
- 非小細胞肺癌121 項研究
- 癌症（所有類型）109 項研究
- 前列腺癌103 項研究
- 轉移性癌症93 項研究
- 大腸直腸癌78 項研究
- 卵巢癌69 項研究
- 肺癌60 項研究
- 多發性骨髓瘤60 項研究
- 胰臟癌60 項研究
- 子宮內膜癌52 項研究
- 急性髓系白血病51 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。